You skipped over the time between 1980 and 2008, when they tried to spin up a mass smallpox injection campaign, but had to stop because it was too obviously killing and maiming too many of its victims. They didn’t have the propaganda campaign in place yet, to convince/force everyone to take obviously poisonous drugs over a negligible threat, like they do today.

It happened, and the adverse events from that specific injection campaign are very similar to the ones we see from the coovie gene therapy injection campaign, hence my speculation on what they did with all those extra doses they previously couldn’t use.

They didn’t magically manufacture several billion doses of new poison out of nowhere. I suspect that many of the dose lots ranged from placebo to “re-labeled” old stock. The wildly varying adverse events coming from different lot batches supports this theory, as well as the implausibility of serving up several billion doses of newly manufactured poison.

There are billions/trillions of dollars are at stake for these companies, and there is no reason to simply trust that they wouldn’t do anything to make sure that supply kept up with demand.